INVENTIVA (EPA:IVA) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
INVENTIVA

BRIEF

published on 07/02/2025 at 22:05, 7 months 5 days ago

Inventiva Publishes Promising Results on Lanifibranor for Liver Disease

Phase 2b Study Liver Disease Lanifibranor MASH Treatment Journal Of Hepatology Reports
PRESS RELEASE

published on 07/02/2025 at 22:00, 7 months 5 days ago

Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease
Inventiva announces publication in Journal of Hepatology Reports on lanifibranor treatment effects on liver sinusoidal endothelial cells in MASLD/MASH patients and preclinical models, showing potential therapeutic benefits

Inventiva MASH Lanifibranor Journal Of Hepatology Reports LSEC Capillarization
BRIEF

published on 06/10/2025 at 22:05, 7 months 27 days ago

Renée Aguiar-Lucander Joins Inventiva's Board of Directors

Board Of Directors Biopharmaceutical Inventiva Lanifibranor Renée Aguiar-Lucander
PRESS RELEASE

published on 06/10/2025 at 22:00, 7 months 27 days ago

Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors
Inventiva appoints Renée Aguiar-Lucander to its Board of Directors. Aguiar-Lucander brings extensive industry experience and leadership to the company

Board Of Directors Biopharmaceutical Inventiva Lanifibranor Renée Aguiar-Lucander
BRIEF

published on 05/27/2025 at 22:05, 8 months 11 days ago

Inventiva at the Jefferies and UBS Healthcare Conferences

Biopharmaceuticals Inventiva MASH UBS Conference Jefferies Conference
PRESS RELEASE

published on 05/27/2025 at 22:00, 8 months 11 days ago

Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference
Inventiva to participate in Jefferies Global Healthcare Conference & UBS Spring Biotech Conference. CEO to present at fireside chat in New York City

Clinical-stage Biopharmaceutical Company Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
BRIEF

published on 05/23/2025 at 08:35, 8 months 16 days ago

Inventiva Reports First Quarter 2025 Financials: Cash Position Declines

Financial Results Cash Position Clinical Trial Inventiva Lanifibranor
PRESS RELEASE

published on 05/23/2025 at 08:30, 8 months 16 days ago

Inventiva reports 2025 First Quarter Financial Information¹
Inventiva reports €67.9 million in cash and cash equivalents for Q1 2025. Forecasted funds to support operations until Q3 2026. Key milestones include Phase 3 trial results expected in late 2026

Financial Information Inventiva Q1 2025 Cash Equivalents NATiV3 Trial
BRIEF

published on 05/22/2025 at 14:05, 8 months 16 days ago

Inventiva Unveils Details of Share Repurchase Program

Share Repurchase Liquidity Agreement Capital Reduction Market Stability Employee Stock Options
PRESS RELEASE

published on 05/22/2025 at 14:00, 8 months 16 days ago

Description of the Share Repurchase Program Covered by the Liquidity Agreement with Kepler Chevreux
Inventiva implements share repurchase program with Kepler Chevreux under liquidity agreement approved by Ordinary General Meeting. Program details and objectives announced for 18-month period

Liquidity Agreement Ordinary General Meeting Share Repurchase Program Inventiva Kepler Chevreux

Accesswire

Published on 02/07/2026 at 01:00, 1 day 10 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 12 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 13 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 20 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 22 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 14 hours 30 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 18 hours 55 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 19 hours 10 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 16 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 17 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 17 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 19 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 16 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 17 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 17 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE